HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Veronica Gillispie Selected Research

Leiomyoma (Uterine Fibroids)

9/2021Efficacy and safety of elagolix with add-back therapy in women with uterine fibroids and coexisting adenomyosis.
1/2021Predictors of response for elagolix with add-back therapy in women with heavy menstrual bleeding associated with uterine fibroids.
1/2020Elagolix Treatment for Up to 12 Months in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Veronica Gillispie Research Topics

Disease

3Leiomyoma (Uterine Fibroids)
09/2021 - 01/2020
3Menorrhagia
09/2021 - 01/2020
2Nausea
09/2021 - 01/2020
1Adenomyosis
09/2021
1Amenorrhea
01/2021
1Headache (Headaches)
01/2020
1Obesity
01/2016

Drug/Important Bio-Agent (IBA)

3elagolixIBA
09/2021 - 01/2020
2Gonadotropin-Releasing Hormone (GnRH)FDA Link
09/2021 - 01/2020
1Estradiol (Delestrogen)FDA LinkGeneric
01/2021
1Hemin (Panhematin)FDA Link
01/2021
1Norethindrone Acetate (Norlutate)FDA LinkGeneric
01/2021

Therapy/Procedure

3Therapeutics
09/2021 - 01/2020
1Cesarean Section (Caesarean Section)
01/2016